Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

TNF-α may mediate link between psychotic symptoms and malaria

03 Feb 2019
Only certain species of mosquitoes of the Anopheles genus – and only females of those species – can transmit malaria.

Tumour necrosis factor (TNF)-α plays a role in the pathogenesis of malaria and psychotic symptoms, independently, and may potentially mediate a link between the two, a recent study has shown.

The study included 1,158 adults (mean age 40.3±17.7 years; 50.6 percent female), in whom the mean log of the CD4-to-CD3 ratio was 0.18±0.04. This value was slightly elevated in patients infected with malaria, but were not significantly changed in those with any common mental disorders (CMD) or psychotic symptoms.

In addition, participants with malaria also showed elevated levels of interleukin (IL)-10 and reduced concentrations of TNF-α. Unadjusted bivariate analysis identified high vs low log10TNF-α as the only marker marginally correlated with the risk of malaria (odds ratio [OR], 0.3; 0.06–1.27; p=0.097).

In comparison, levels of IL-6, 8 and 10 were raised in participants with one or more psychotic symptoms, while concentrations of IL-1β were reduced, relative to individuals without. Participants with vs without CMD, on the other hand, showed higher levels of IL-8 and 10.

Fully-adjusted multivariate models showed that log10TNF-α was significantly associated with the risk of psychotic symptoms (adjusted OR, 1.3; 1.09–1.51; p=0.003), but not with that of CMD (adjusted OR, 2.9; 2.36–3.77; p=0.566).

“Our findings support the key role of TNF-α in the pathogenesis of both CMD and psychotic symptoms, and suggest that TNF-α may mediate the association between malaria and CMD. Further community studies should be longitudinal, use [polymerase chain reaction], measure anaemia and extend the range of immune markers used,” said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.